Association of the cytotoxic T lymphocyte-associated antigen 4 gene with type 1 diabetes: Evidence for independent effects of two polymorphisms on the same haplotype block

被引:53
作者
Anjos, SM [1 ]
Tessier, MC [1 ]
Polychronakos, C [1 ]
机构
[1] McGill Univ, Hlth Sci Ctr, Dept Pediat, Endocrine Genet Lab,Div Pediat Endocrinol, Montreal, PQ H3H 1P3, Canada
关键词
D O I
10.1210/jc.2004-0881
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A recent study mapped the known association of type 1 diabetes with the cytotoxic T lymphocyte-associated antigen 4 gene to a polymorphism at the 3' end (+6230G>A), but could not rule out additional contribution from the 5' end of the gene. To examine this possibility, we analyzed four polymorphisms at the 5'-flanking region for effects independent of +6230G>A. We confirm, by the transmission disequilibrium test, in 496 family trios overtransmission of the susceptibility allele (G) at +6230 (217/168; P = 0.013). Of the four promoter polymorphisms, one (-319C>T) showed overtransmission of the C allele (97/58; P = 0.0017). Because the undertransmitted T at the promoter is in linkage disequilibrium with the overtransmitted G at +6230G>A, the effect observed at the promoter cannot be accounted for by linkage disequilibrium with the +6230G>A. We confirm this by showing that parents heterozygous at the promoter but homozygous at +6230 overtransmit the C promoter allele even more significantly (53/24; P = 9 x 10(-4)). In vitro, the T promoter allele directs higher luciferase expression in Jurkat cells by 42% (P = 0.006), a difference also found in lymphocyte mRNA from eight individuals heterozygous at the promoter, but homozygous at +6230 (P = 1.3 x 10(-4)). Thus, the +6230G>A cannot be the sole functional variant. Either the two polymorphisms define a haplotype carrying the (yet unexamined) functional variant or the -319C>T contributes to the genetic association independently, a possibility suggested by the functional evidence we present.
引用
收藏
页码:6257 / 6265
页数:9
相关论文
共 51 条
  • [41] THOMSON G, 1988, AM J HUM GENET, V43, P799
  • [42] LOSS OF CTLA-4 LEADS TO MASSIVE LYMPHOPROLIFERATION AND FATAL MULTIORGAN TISSUE DESTRUCTION, REVEALING A CRITICAL NEGATIVE REGULATORY ROLE OF CTLA-4
    TIVOL, EA
    BORRIELLO, F
    SCHWEITZER, AN
    LYNCH, WP
    BLUESTONE, JA
    SHARPE, AH
    [J]. IMMUNITY, 1995, 3 (05) : 541 - 547
  • [43] HLA ANTIGENS AND INSULIN-DEPENDENT DIABETES
    TODD, JA
    BELL, JI
    MCDEVITT, HO
    [J]. NATURE, 1988, 333 (6175) : 710 - 710
  • [44] Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
    Ueda, H
    Howson, JMM
    Esposito, L
    Heward, J
    Snook, H
    Chamberlain, G
    Rainbow, DB
    Hunter, KMD
    Smith, AN
    Di Genova, G
    Herr, MH
    Dahlman, I
    Payne, F
    Smyth, D
    Lowe, C
    Twells, RCJ
    Howlett, S
    Healy, B
    Nutland, S
    Rance, HE
    Everett, V
    Smink, LJ
    Lam, AC
    Cordell, HJ
    Walker, NM
    Bordin, C
    Hulme, J
    Motzo, C
    Cucca, F
    Hess, JF
    Metzker, ML
    Rogers, J
    Gregory, S
    Allahabadia, A
    Nithiyananthan, R
    Tuomilehto-Wolf, E
    Tuomilehto, J
    Bingley, P
    Gillespie, KM
    Undlien, DE
    Ronningen, KS
    Guja, C
    Ionescu-Tirgoviste, C
    Savage, DA
    Maxwell, AP
    Carson, DJ
    Patterson, CC
    Franklyn, JA
    Clayton, DG
    Peterson, LB
    [J]. NATURE, 2003, 423 (6939) : 506 - 511
  • [45] Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy
    Vaidya, B
    Imrie, H
    Perros, P
    Dickinson, J
    McCarthy, MI
    Kendall-Taylor, P
    Pearce, SHS
    [J]. LANCET, 1999, 354 (9180) : 743 - 744
  • [46] CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers
    VanDerAuwera, BJ
    Vandewalle, CL
    Schuit, FC
    Winnock, F
    DeLeeuw, IH
    VanImschoot, S
    Lamberigts, G
    Gorus, FK
    Balasse, E
    Becq, H
    Beirinckx, J
    Claeys, L
    Coeckelberghs, M
    Coolens, JL
    Coucke, W
    Couturier, E
    Craen, R
    Daubresse, JC
    DeSchepper, J
    Delvigne, C
    Dorchy, H
    DuCaju, M
    Fery, F
    Gaham, M
    Gerard, J
    Gillet, C
    Guiot, J
    Herbaut, C
    Keymeulen, B
    Krzentowski, G
    Letiexhe, M
    Monballyu, J
    Moorkens, G
    Nicolaij, D
    Nobels, F
    Pelckmans, MC
    Purnode, A
    Rooman, R
    Rottiers, R
    Scheen, A
    Schutyser, J
    Sodoyez, JC
    Somers, G
    Terriere, L
    Teuwen, J
    Tits, J
    VanAcker, K
    VanCrombrugge, P
    VanGaal, L
    Vandenbussche, E
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 110 (01) : 98 - 103
  • [47] A CTLA-4 gene polymorphism at position-318 in the promoter region affects the expression of protein
    Wang, XB
    Zhao, X
    Giscombe, R
    Lefvert, AK
    [J]. GENES AND IMMUNITY, 2002, 3 (04) : 233 - 234
  • [48] LYMPHOPROLIFERATIVE DISORDERS WITH EARLY LETHALITY IN MICE DEFICIENT IN CTLA-4
    WATERHOUSE, P
    PENNINGER, JM
    TIMMS, E
    WAKEHAM, A
    SHAHINIAN, A
    LEE, KP
    THOMPSON, CB
    GRIESSER, H
    MAK, TW
    [J]. SCIENCE, 1995, 270 (5238) : 985 - 988
  • [49] Allelic variation in human gene expression
    Yan, H
    Yuan, WS
    Velculescu, VE
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 2002, 297 (5584) : 1143 - 1143
  • [50] Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects
    Yanagawa, T
    Maruyama, T
    Gomi, K
    Taniyama, M
    Kasuga, A
    Ozawa, Y
    Terauchi, M
    Hirose, H
    Maruyama, H
    Saruta, T
    [J]. AUTOIMMUNITY, 1999, 29 (01) : 53 - 56